Cargando…

A retro-inverso cell-penetrating peptide for siRNA delivery

BACKGROUND: Small interfering RNAs (siRNAs) are powerful tools to control gene expression. However, due to their poor cellular permeability and stability, their therapeutic development requires a specific delivery system. Among them, cell-penetrating peptides (CPP) have been shown to transfer effici...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaissière, Anaïs, Aldrian, Gudrun, Konate, Karidia, Lindberg, Mattias F., Jourdan, Carole, Telmar, Anthony, Seisel, Quentin, Fernandez, Frédéric, Viguier, Véronique, Genevois, Coralie, Couillaud, Franck, Boisguerin, Prisca, Deshayes, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410048/
https://www.ncbi.nlm.nih.gov/pubmed/28454579
http://dx.doi.org/10.1186/s12951-017-0269-2
Descripción
Sumario:BACKGROUND: Small interfering RNAs (siRNAs) are powerful tools to control gene expression. However, due to their poor cellular permeability and stability, their therapeutic development requires a specific delivery system. Among them, cell-penetrating peptides (CPP) have been shown to transfer efficiently siRNA inside the cells. Recently we developed amphipathic peptides able to self-assemble with siRNAs as peptide-based nanoparticles and to transfect them into cells. However, despite the great potential of these drug delivery systems, most of them display a low resistance to proteases. RESULTS: Here, we report the development and characterization of a new CPP named RICK corresponding to the retro-inverso form of the CADY-K peptide. We show that RICK conserves the main biophysical features of its L-parental homologue and keeps the ability to associate with siRNA in stable peptide-based nanoparticles. Moreover the RICK:siRNA self-assembly prevents siRNA degradation and induces inhibition of gene expression. CONCLUSIONS: This new approach consists in a promising strategy for future in vivo application, especially for targeted anticancer treatment (e.g. knock-down of cell cycle proteins). [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12951-017-0269-2) contains supplementary material, which is available to authorized users.